Study In Adults And Adolescents With Seasonal Allergic Rhinitis.
Phase 3
Completed
- Conditions
- Rhinitis, Allergic, Seasonal
- Registration Number
- NCT00225823
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
Compare the efficacy and safety of an investigational nasal spray compared with placebo nasal spray in the treatment of seasonal allergic rhinitis. Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure. The focus of this study, seasonal allergic rhinitis (SAR), is one type of allergic rhinitis that is triggered by the pollen from trees, grasses, and weeds. Commonly referred to as 'hay fever', it is characterized by sneezing, nasal congestion and pruritus, rhinorrhea, and pruritic, watery, red eyes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 288
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Mean change from baseline over the entire treatment period in daily, reflective, total nasal symptom scores (rTNSS).
- Secondary Outcome Measures
Name Time Method Mean change from baseline over the entire tx period in AM, pre-dose iTNS. Mean change from baseline over the entire treatment period in rTOSS. Overall evaluation of response to therapy.
Trial Locations
- Locations (1)
GSK Investigational Site
🇸🇪Ängelholm, Sweden